On October 11, Natalia Robledinos (GT2 group) and Clara Herrera (GT3 group) defended their doctoral thesis entitled “Orchestration of the neural stem cell fate by NRF2 and TAZ” and “Melatonin- and resveratrol-based multitarget-directed agents for Alzheimer’s disease and photoswitchable muscular nicotinic receptor ligands” respectively.
Thank you very much for your effort and the contributions you have made to this project.
Congratulations!